Skip to main content
SpringerLink
Log in

Drugs major player in varying hospitalisation costs of CF

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Schreyögg J, Hollmeyer H, Bluemel M, Staab D, Busse R.Hospitalisation costs of cystic fibrosis. PharmacoEconomics 24: 999-1009, No. 10, 2006

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drugs major player in varying hospitalisation costs of CF. Pharmacoecon. Outcomes News 514, 5 (2006). https://doi.org/10.2165/00151234-200605140-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605140-00009

Keywords

Search

Navigation